In new clinical trials, a gene therapy for a serious blood disorder called beta-thalassemia significantly improved outcomes among patients, without serious side effects.
Browsing: Clinical Breakthroughs
A new study shows a patient’s overall heart disease risk assessment can better determine blood pressure treatment, as opposed to examining blood pressure levels alone.
Patients with advanced prostate cancer who received more intensive treatment experienced worse quality of life at three months, but better overall in the long-term, according to a new Northwestern Medicine study.
Infant and childhood food allergy, whose cause has long been a mystery, has now been linked to a mix of environmental and genetic factors that must coexist to trigger the allergy, reports a new Northwestern Medicine study.
A drug called dasatinib was found to be safe and effective for children with chronic myeloid leukemia, according to a study published in the Journal of Clinical Oncology.
Among patients with stage III colon cancer, regular nut consumption was associated with significantly lower rates of cancer recurrence and death, according to a new study.
A sudden loss of net worth in middle or older age is associated with a significantly higher risk of death, according to a new study.
A recent trend of using hospital volume as a surrogate measure of cardiovascular care may not accurately represent quality, according to a recent study published in Circulation.
A new study has found that obese patients with metastatic melanoma live significantly longer than those with a normal body mass index — especially male patients treated with targeted or immune therapy.